Literature DB >> 16004573

In vivo magnetic resonance spectroscopy in cancer.

Robert J Gillies1, David L Morse.   

Abstract

Magnetic resonance spectroscopy (MRS) has been used for more than two decades to interrogate metabolite distributions in living cells and tissues. Techniques have been developed that allow multiple spectra to be obtained simultaneously with individual volume elements as small as 1 uL of tissue (i.e., 1 x 1 x 1 mm(3)). The most common modern applications of in vivo MRS use endogenous signals from (1)H, (31)P, or (23)Na. Important contributions have also been made using exogenous compounds containing (19)F, (13)C, or (17)O. MRS has been used to investigate cardiac and skeletal muscle energetics, neurobiology, and cancer. This review focuses on the latter applications, with specific reference to the measurement of tissue choline, which has proven to be a tumor biomarker that is significantly affected by anticancer therapies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16004573     DOI: 10.1146/annurev.bioeng.7.060804.100411

Source DB:  PubMed          Journal:  Annu Rev Biomed Eng        ISSN: 1523-9829            Impact factor:   9.590


  82 in total

Review 1.  Stable isotope-resolved metabolomics and applications for drug development.

Authors:  Teresa W-M Fan; Pawel K Lorkiewicz; Katherine Sellers; Hunter N B Moseley; Richard M Higashi; Andrew N Lane
Journal:  Pharmacol Ther       Date:  2011-12-23       Impact factor: 12.310

2.  Metabolite detection of pancreatic carcinoma by in vivo proton MR spectroscopy at 3T: initial results.

Authors:  X Yao; M Zeng; H Wang; S Fei; S Rao; Y Ji
Journal:  Radiol Med       Date:  2011-11-17       Impact factor: 3.469

3.  Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.

Authors:  Egidio Iorio; Alessandro Ricci; Marina Bagnoli; Maria Elena Pisanu; Giancarlo Castellano; Massimo Di Vito; Elisa Venturini; Kristine Glunde; Zaver M Bhujwalla; Delia Mezzanzanica; Silvana Canevari; Franca Podo
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

4.  Natural linewidth chemical shift imaging (NL-CSI).

Authors:  Adil Bashir; Dmitriy A Yablonskiy
Journal:  Magn Reson Med       Date:  2006-07       Impact factor: 4.668

5.  Imaging readouts as biomarkers or surrogate parameters for the assessment of therapeutic interventions.

Authors:  Markus Rudin
Journal:  Eur Radiol       Date:  2007-03-06       Impact factor: 5.315

6.  Metabolic remodeling of malignant gliomas for enhanced sensitization during radiotherapy: an in vitro study.

Authors:  Chaim B Colen; Navid Seraji-Bozorgzad; Brian Marples; Matthew P Galloway; Andrew E Sloan; Saroj P Mathupala
Journal:  Neurosurgery       Date:  2006-12       Impact factor: 4.654

7.  pH imaging of mouse kidneys in vivo using a frequency-dependent paraCEST agent.

Authors:  Yunkou Wu; Shanrong Zhang; Todd C Soesbe; Jing Yu; Elena Vinogradov; Robert E Lenkinski; A Dean Sherry
Journal:  Magn Reson Med       Date:  2015-07-14       Impact factor: 4.668

8.  Evaluations of extracellular pH within in vivo tumors using acidoCEST MRI.

Authors:  Liu Qi Chen; Christine M Howison; Justin J Jeffery; Ian F Robey; Phillip H Kuo; Mark D Pagel
Journal:  Magn Reson Med       Date:  2013-11-26       Impact factor: 4.668

9.  Choline PET for monitoring early tumor response to photodynamic therapy.

Authors:  Baowei Fei; Hesheng Wang; Chunying Wu; Song-mao Chiu
Journal:  J Nucl Med       Date:  2009-12-15       Impact factor: 10.057

10.  Metabolic reprogramming and validation of hyperpolarized 13C lactate as a prostate cancer biomarker using a human prostate tissue slice culture bioreactor.

Authors:  Kayvan R Keshari; Renuka Sriram; Mark Van Criekinge; David M Wilson; Zhen J Wang; Daniel B Vigneron; Donna M Peehl; John Kurhanewicz
Journal:  Prostate       Date:  2013-03-26       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.